Bariatric Surgical Management of Morbid Obesity
JH · Effective Oct 1, 2015
23 active Medicare policies list E13.3319, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Jan 22, 2023
JM · Effective Jan 22, 2023
J9 · Effective Oct 1, 2015
JJ · Effective Jan 29, 2018
JM · Effective Jan 29, 2018
3 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of E13.3319 |
|---|---|---|
| Fluocinolone Acetonide Intra-vitreal Implant (Retisert, Yutiq and Iluvien) | Jan 5, 2024 | Covered |
| Retinopathy Telescreening Systems | Aug 10, 2023 | Covered |
| Policy | Effective | Status of E13.3319 |
|---|---|---|
| Susvimo (Ranibizumab Injection) | Aug 1, 2026 | Covered |
J9 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JL · Effective Jan 1, 2026
National · Effective Oct 1, 2026
J5 · Effective Oct 1, 2025
National · Effective Apr 17, 2025
National · Effective Oct 1, 2026
National · Effective Nov 1, 2025
National · Effective Oct 1, 2025
J9 · Effective Jan 1, 2026
J9 · Effective Oct 1, 2025
National · Effective Jan 25, 2026
National · Effective Feb 18, 2025
National · Effective Dec 5, 2024